BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santos P, López-Vallejo F, Soto CY. In silico approaches and chemical space of anti-P-type ATPase compounds for discovering new antituberculous drugs. Chem Biol Drug Des 2017;90:175-87. [PMID: 28111912 DOI: 10.1111/cbdd.12950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Sepehri B, Ghavami R. The identification of new ATAD2 bromodomain inhibitors: the application of combined ligand and structure-based virtual screening. SAR and QSAR in Environmental Research 2017;28:957-71. [DOI: 10.1080/1062936x.2017.1385532] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Singh P, Kumari R, Lal R. Bedaquiline: Fallible Hope Against Drug Resistant Tuberculosis. Indian J Microbiol 2017;57:371-7. [PMID: 29151636 DOI: 10.1007/s12088-017-0674-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
3 Santos P, Lopez-Vallejo F, Ramírez D, Caballero J, Mata Espinosa D, Hernández-Pando R, Soto CY. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds. Bioorg Med Chem 2020;28:115256. [PMID: 31879181 DOI: 10.1016/j.bmc.2019.115256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]